Dc. Schwenke et Sr. Behr, alpha-tocopherol and probucol reduce autoantibody titer to MDA-LDL in hypercholesterolemic rabbits, FREE RAD B, 31(6), 2001, pp. 778-789
We considered the hypothesis that antioxidant supplementation that increase
s aortic antioxidant concentrations would reduce autoantibody titer to MDA-
LDL, a measure that may indicate in vivo oxidation. We assessed autoantibod
y titer to NMA-LDL in rabbits before and after 5 months of treatment with a
nutritionally adequate hypercholesterolemic diet alone (control) or supple
mented with synthetic alpha -tocopherol or probucol. Aortic cholesterol and
antioxidants were assessed at the end of treatment. alpha -Tocopherol supp
lementation increased the ratio of aortic alpha -tocopherol to cholesterol
by 20-30-fold, while probucol supplementation increased the ratio of aortic
probucol to cholesterol to 4-13 mu mol/mol. Before treatment, MDA-LDL auto
antibody titer averaged 5.09 +/- 0.24 with no difference among groups (p =
.53 by ANOVA). However, after treatment, autoantibody titers differed among
groups (p < .03 by ANOVA). Autoantibody titers were similar in rabbits sup
plemented with alpha -tocopherol and probucol (3.69 +/- 0.21 and 3.73 +/- 0
.48, respectively, p = 0.81), and 26% (p < .009) lower in antioxidant suppl
emented rabbits than unsupplemented hypercholesterolemic rabbits (5.03 +/-
0.47). There was an inverse J relationship between autoantibody titer after
treatment and aortic alpha -tocopherol/cholesterol and probucol/cholestero
l, with minimum values for autoantibody titers above 8-10 mu mol antioxidan
t(mmol cholesterol. The results of this study are consistent with inhibitio
n of in vivo intra-aortic oxidation when aortic alpha -tocopherol or probuc
ol exceed 8-10 mu mol/mmol cholesterol. (C) 2001 Elsevier Science Inc.